Table 2 Correlation between HBV serological markers in treatment-naïve patients
From: Levels of HBV RNA in chronic HBV infected patients during first-line nucleos(t)ide analogues therapy
HBV DNA | HBsAg | |
|---|---|---|
All treatment-naïve patients (n = 82) | ||
HBV RNA | 0.602(P < 0.05*) | 0.502(P < 0.05*) |
HBV DNA | – | 0.496(P < 0.05*) |
HBeAg-Positive (n = 53) | ||
HBV RNA | 0.445(P < 0.05*) | 0.413(P < 0.05*) |
HBV DNA | – | 0.442(P < 0.05*) |
HBeAg-Negative (n = 29) | ||
HBV RNA | 0.478(P < 0.05*) | 0.352(P = 0.061) |
HBV DNA | – | 0.265(P = 0.165) |
Chronic hepatitis B (n = 62) | ||
HBV RNA | 0.598(P < 0.05*) | 0.515(P < 0.05*) |
HBV DNA | – | 0.551(P < 0.05*) |
Liver cirrhosis (n = 20) | ||
HBV RNA | 0.700(P < 0.05*) | 0.367(P = 0.112) |
HBV DNA | – | 0.278(P = 0.235) |